Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-25-123739·Indivior Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
INDIVIOR PLC
Ordinary Shares, $0.50 nominal value per share · CUSIP: G4766E116
Event date: 2025-12-15
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Millennium Management LLC
Shares: 2,461,370.00 · Class: 2.0%
- Millennium Group Management LLC
Shares: 2,461,370.00 · Class: 2.0%
- Israel A. Englander
Shares: 2,461,370.00 · Class: 2.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-123739
- Form type
- SCHEDULE 13G
- Filer
- Indivior Pharmaceuticals, Inc.
- CIK
- CIK 1625297
- Filed
- Dec 22, 2025
- Reporting period
- Dec 15, 2025
- Description
- Schedule 13G beneficial ownership